𝔖 Bobbio Scriptorium
✦   LIBER   ✦

System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner

✍ Scribed by Robert C. Susil; Kevin Camphausen; Peter Choyke; Elliot R. McVeigh; Gary S. Gustafson; Holly Ning; Robert W. Miller; Ergin Atalar; C. Norman Coleman; Cynthia Ménard


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
449 KB
Volume
52
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A technique for transperineal high‐dose‐rate (HDR) prostate brachytherapy and needle biopsy in a standard 1.5 T MRI scanner is demonstrated. In each of eight procedures (in four patients with intermediate to high risk localized prostate cancer), four MRI‐guided transperineal prostate biopsies were obtained followed by placement of 14–15 hollow transperineal catheters for HDR brachytherapy. Mean needle‐placement accuracy was 2.1 mm, 95% of needle‐placement errors were less than 4.0 mm, and the maximum needle‐placement error was 4.4 mm. In addition to guiding the placement of biopsy needles and brachytherapy catheters, MR images were also used for brachytherapy treatment planning and optimization. Because 1.5 T MR images are directly acquired during the interventional procedure, dependence on deformable registration is reduced and online image quality is maximized. Magn Reson Med 52:683–687, 2004. Published 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


In vivo cellular imaging of magnetically
✍ Pierre Smirnov; Florence Gazeau; Maïté Lewin; Jean Claude Bacri; Nathalie Siauve 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

The feasibility of in vivo cellular imaging using a 1.5 T clinical magnet was studied in the mouse. Hybridoma cells were labeled with anionic gamma-Fe2O3 superparamagnetic iron oxide nanoparticles. These were internalized by the endocytose pathway. Both electron spin resonance and magnetophoresis as

Free PSA isoforms and intact and cleaved
✍ Thomas Steuber; Andrew Vickers; Alexander Haese; Michael W. Kattan; James A. Eas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

## Abstract Clinicians currently use simple cut‐points, such as serum prostate‐specific antigen (PSA) ≥≥4 ng/ml, to decide whether to recommend further work‐up for prostate cancer (PCa). As an alternative strategy, we evaluated multivariable models giving probabilities of a PCa diagnosis based on P